BioVaxys Technology Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Apr '25 Apr 2, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	2019
Market Capitalization	15	19	4	22	34	30	Upgrade
Market Cap Growth	404.25%	404.25%	-83.41%	-34.60%	14.06%	-	Upgrade
Enterprise Value	14	18	4	22	33	30	Upgrade
Last Close Price	0.05	0.07	0.03	0.20	0.37	0.42	Upgrade
PB Ratio	-9.72	-9.72	-1.10	-28.84	4.17	3.13	Upgrade
P/TBV Ratio	-	-	-	-	43.74	13.83	Upgrade
Debt / Equity Ratio	-0.04	-0.04	-	-	-	-	Upgrade
Quick Ratio	0.20	0.20	0.03	0.11	1.96	2.75	Upgrade
Current Ratio	0.40	0.40	0.03	0.44	2.68	3.40	Upgrade
Return on Equity (ROE)	-	-	-	-316.82%	-72.82%	-22.62%	Upgrade
Return on Assets (ROA)	-275.96%	-275.96%	-306.75%	-50.74%	-39.41%	-11.72%	Upgrade
Return on Capital (ROIC)	-	-	-	-64.21%	-42.14%	-12.94%	Upgrade
Earnings Yield	-38.03%	-21.20%	-207.75%	-52.57%	-18.93%	-3.93%	Upgrade
Buyback Yield / Dilution	-45.90%	-45.90%	-36.63%	-18.39%	-193.97%	-171.65%	Upgrade

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.